Canaccord Genuity Maintains Buy on DexCom, Raises Price Target to $195

Canaccord Genuity maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $185 to $195.

Benzinga · 11/07/2019 15:52

Canaccord Genuity maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $185 to $195.